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Sergej M Ostojic* and Milos ObrenovicAbstract
Evidence exists regarding the potential role of exogenous nucleotides as regulators of the immune function in
physically active humans, yet the potential use of nucleotides has been hindered by their low bioavailability after
oral administration. We conducted a double-blind, placebo-controlled, randomized trial to assess the effect of
sublingual nucleotides (50 mg/day) on salivary and serum immunity indicators as compared to placebo, both
administered to healthy males aged 20 to 25 years for 14 days. Sublingual administration of nucleotides for 14 days
increased serum immunoglobulin A, natural killer cells count and cytotoxic activity, and offset the post-exercise
drop of salivary immunoglobulins and lactoferrin (P< 0.05), with no adverse effects reported. No significant
differences in fasting salivary antimicrobal proteins (α-amylase, lysozyme and lactoferrin) were found before or after
the treatment (P> 0.05). It seems that sublingual administration of nucleotides for two weeks considerably affected
immune function in healthy males.
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Nucleotides are a group of molecules that, when linked
together, form the building blocks of RNA and DNA,
participate in cellular signaling (e.g. cyclic guanosine and
adenosine monophosphates), and are incorporated into
important cofactors of enzymatic reactions (e.g., coen-
zyme A, flavin adenine dinucleotide, flavin mononucleo-
tide, and nicotinamide adenine dinucleotide phosphate).
Nucleotides are synthesized endogenously and have im-
portant effects on the growth and development of cells
with a rapid turnover, such as those of the immune sys-
tem [1]. However, under certain circumstances exogen-
ous nucleotides may be semi-essential, optimizing the
function of the immune system when the endogenous
supply may limit the synthesis of nucleotides. Exogenous
nucleotides appear to be required for the maintenance
of the host immunity in impaired immune responses,
such as heavy exercise-related suppression of immune
parameters [2]. Oral supplementation with nucleotides
in physically active males may offset the hormonal re-
sponse associated with demanding endurance exercise
[3], and boost immune responses to a short term high* Correspondence: sergej@panet.rs
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distribution, and reproduction in any mediumintensity exercise [4]. Yet, its use is hampered by low
bioavailability following oral administration [5]. To avoid
the degradation of nucleotides in the gastrointestinal
tract and first pass metabolism in the liver after oral in-
take, sublingual administration of nucleotides may be
the more advantageous route of application. No studies
so far examined the immunostimulatory effects of sub-
lingual nucleotides in humans. Therefore, we investi-
gated whether daily sublingual administration of 50 mg
of nucleotides formulation for 14 days affected indica-
tors of the immune system at baseline and post-exercise
in young healthy men.Methods
We conducted a double-blind, placebo-controlled, ran-
domized pilot trial to assess the effect of sublingual
nucleotides (50 mg daily divided into three portions to
be taken at regular intervals throughout the day) as
compared to placebo, both administered for 14 days in
healthy male participants aged 20 to 25 years. A total of
38 participants were randomly assigned to receive
nucleotides (n =19) or placebo (n =19) and were instru-
mented for saliva and blood sampling, and endurance
running test at the start (day 0) and at the end of the
intervention period (day 14). Placebo (inulin) was similard Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(nucleotides vs. placebo) were homogenous for age,
height, body mass index, body fat, and maximal oxygen
uptake. Venous blood samples were collected after an
overnight fast, with white blood cell count (WBC),
natural killer cells (NKC) number, NKC cytotoxic activ-
ity and serum immunoglobulins (IgA, IgM, IgG) con-
centration determined. Unstimulated saliva samples
were provided at morning and following the endurance
running test for determination of salivary immunoglo-
bulins (SIgA, SIgM, SIgG) and antimicrobial proteins
(α-amylase, lysozyme, lactoferrin). Exercise test was per-
formed according to the incremental protocol using a
treadmill system (Trackmaster TMX425C, Newton, KS,
USA). The running protocol consisted of 1-min work-
loads with participants beginning at a running speed of
8 km/h and increased by 2 km/h for each of subsequent
workloads until volitional exhaustion. Duration of the
running protocol was identical at day 0 and day 14. Par-
ticipants were asked to maintain their usual dietary in-
take and not to change their physical activity patterns
during the study. Participants were instructed to report
any side-effects of administration (e.g. headache, diar-
rhea, nausea, weight gain) through an open-ended ques-
tionnaire. Two-way analysis of variance (ANOVA) with
repeated measures was used to establish if any signifi-
cant differences existed between subjects’ responses
over time of intervention (0 vs. 2 weeks). Where signifi-
cant differences were found, the Tukey test was
employed to identify the differences. P values of less
than 0.05 were considered statistically significant.
Effects-sizes in two way ANOVA with replication after
two weeks of administration were assessed by CohenFigure 1 Percentage change of fasting salivary and serum immunolog
killer cells, and WBC white blood cells. * Indicates significance (P< 0.05) forstatistics, with r> 0.24 indicated medium effect of
mixed factors. The data were analyzed using the statis-
tical package SPSS 16.0, PC program (IBM SPSS Data
Collection, New York, NY, USA).
Results
Changes in fasting salivary and serum immunological
profiles during the study are presented in Figure 1.
Results indicated significant treatment × time interaction
for salivary immunoglobulin A (P = 0.0002; r= 0.26),
salivary immunoglobulin M (P = 0.02; r= 0.15), serum
immunoglobulin A (P = 0.02; r= 0.16), NKC count
(P = 0.01; r= 0.17), and NKC cytotoxic activity (P = 0.003;
r= 0.25). Salivary immunoglobulin A increased sig-
nificantly from before to after administration in
nucleotides-administered participants (19.4 ± 3.5 vs.
25.6 ± 5.0 ml/100 mL; 95% CI 3.3–9.1, P< 0.0001;
r= 0.58). There were no significant differences in salivary
and serum immunological outcomes before and after ad-
ministration in the placebo group. After 14 days of ad-
ministration, the nucleotides group had higher levels of
serum immunoglobulin A than the placebo group
(246.8 ± 22.5 vs. 201.4 ± 16.9 μmol/L, 95% confidence
interval [CI] 32.3–58.5, P< 0.0001; r= 0.75), and higher
levels of NKC cytotoxic activity (50.4 ± 14.5 vs.
29.3 ± 8.7 LU, 95% CI 13.2–29.0, P< 0.0001; r= 0.66).
Salivary measures of immunity were significantly lower
after the exercise trial in both nucleotides and placebo
groups before as well as after the administration period
(P< 0.05). Yet, administration of nucleotides for 14 days
significantly diminished the drop of salivary immunoglo-
bulins A (P =0.04; r= 0.13), salivary immunoglobulins M
(P = 0.004; r= 0.18), and salivary lactoferrin afterical indices 0 vs. 14 days. Ig denotes immunoglobulin, NKC natural
the interaction effect (treatment × time).
Figure 2 Post-exercise changes in salivary immunological indices at baseline and after the intervention. Ig denotes immunoglobulin, PLA
placebo group, and NUC nucleotides group. * Indicates significance (P< 0.05) for the pre vs. post administration.
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teers withdrew before the end of the study and no parti-
cipants reported any vexatious side effect of the
supplementation.
Discussion
The oral application of nucleotides is not a new concept
yet only a few human studies evaluated modulation of
the immune response mediated by dietary nucleotides.
Exogenous nucleotides have been reported beneficial, es-
pecially in infants when the nutrition supply was inad-
equate, since they positively affect NKC activity and
production of interleukin-2 [6], plasma levels of im-
munoglobulin M [7], and antibody response [8]. In two
studies by Mc Naughton and co-workers [3,4] the
authors reported an increase in the level of salivary im-
munoglobulin A in a group of physically active males
supplemented with nucleotides for 60 days. In the
present study, sublingual administration of nucleotides
formulation for 14 days increased serum immunoglobu-
lin A, NKC count and cytotoxic activity, and offset the
post-exercise drop of salivary immunoglobulins M and
A in healthy volunteers, with no adverse effects reported.
This implies that nucleotides are absorbed from the mu-
cous membrane under the tongue, enter the circulation
and are available for lymphocyte subpopulation activa-
tion and proliferation, and modulation of immunoglobu-
lin production. The precise mechanism of the effects of
oral nucleotides on cellular immunity is not clear. Gill
[1] suggested that the exogenous nucleotides may either
affect initial phase of the antigen processing and
lymphocyte proliferation, modulate T-helper cell-
mediated antibody production, or mediate signal mem-
brane transduction and expression of a number of genes,
some of which can directly affect the levels of cell-signaling protein molecules. Further studies are needed
to explicate the mechanism of immunostimulatory
effects of the sublingual nucleotides, with longer admin-
istration protocol and a higher dosage of the formula-
tion, along with proven bioavailability coupled with
monitoring of the other indicators of immunity. Our
study suggests that the immunostimulatory potential of
sublingual nucleotides in healthy subjects is superior as
compared to oral intervention, since oral nucleotides
significantly raised salivary immunoglobulin A by up to
5% and attenuate the drop in post-exercise IgA by up to
3% [3], while bioavailability after oral nucleotides admin-
istration was less than 10% [5,9].
In conclusion, it appears that sublingual nucleotides
(50 mg per day) strongly influence immunity in healthy
males when administered for two weeks, with a signifi-
cant increase in fasting salivary and serum immunity
indicators. Participants supplemented with nucleotides
experienced reduced post-exercise drop of salivary
immunoglobulins M and A for up to 7%. Salivary nu-
cleotide supplement had an acceptable safety profile with
no incidence of side-effects reported.
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